N. P. Fitriani and Suyata, “The Role of Anti-PD 1 (Programmed Cell Death-1) (Pembrolizumab) in Hepatocellular Carcinoma: A Narrative Literature Review”, Bioscmed, vol. 8, no. 4, pp. 4289-4296, Feb. 2024.